Expression and characterization of rat soluble catechol-O-methyltransferase fusion protein

被引:15
作者
Bonifácio, MJ [1 ]
Vieira-Coelho, MA [1 ]
Soares-da-Silva, P [1 ]
机构
[1] BIAL, Dept Res & Dev, P-4745457 Sao Mamede Coronado, Portugal
关键词
recombinant catechol-O-methyltransferase; fusion protein; kinetic analysis; COMT inhibitor;
D O I
10.1006/prep.2001.1477
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Rat soluble catechol-O-methyltransferase cDNA was cloned into the pCAL-n-FLAG vector and expressed in Escherichia coli as a fusion protein with a calmodulin-binding peptide tag. The recombinant protein, comprising up to 30% of the total protein in the soluble fraction of E. coli, was purified by calmodulin affinity chromatography and gel filtration. Up to 16 mg of pure recombinant enzyme was recovered per liter of culture. Recombinant catechol-O-methyltransferase, in the bac. terial soluble fraction, exhibited the same affinity for adrenaline as rat liver soluble catechol-O-methyltransferase (K-m 428 [246, 609] muM and 531 [330, 732] muM, respectively), as well as the same affinity for the methyl donor, S-adenosyl-L-methionine (K-m 27 [9, 45] muM and 38 [21,55] muM, respectively). In addition, both the recombinant and the liver enzymes displayed the same sensitivity to the inhibitor 3,5-dinitrocatechol (IC50 132 [44, 397] nM and 74 [38,143] nM, respectively), and both had the same catalytic number, respectively, 10.1 +/- 1.5 min(-1) and 8.3 +/- 0.3 min(-1). The purified recombinant enzyme also displayed the same affinity for the substrate as the purified rat liver catechol-O-methyltransferase (K-m 336 [75, 597] muM and 439 [168, 711] muM, respectively) as well as the same inhibitor sensitivity (IC50 44 [19, 101] nM and 61 [33, 111] nM, respectively). This recombinant form of catechol-O-methyltransferase is kinetically identical to the rat liver enzyme. This system provides an easy and quick way of obtaining large amounts of soluble catechol-O-methyltransferase for both pharmacological and structural studies. (C) 2001 Academic Press.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 32 条
[1]  
AXELROD J, 1958, J BIOL CHEM, V233, P702
[2]  
Bonifacio M. J., 2000, British Journal of Pharmacology, V131, p6P
[3]   Kinetics of rat brain and liver solubilized membrane-bound catechol-O-methyltransferase [J].
Bonifácio, MJ ;
Vieira-Coelho, MA ;
Borges, N ;
Soares-da-Silva, P .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 384 (02) :361-367
[4]   New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease [J].
Bonifati, V ;
Meco, G .
PHARMACOLOGY & THERAPEUTICS, 1999, 81 (01) :1-36
[5]  
Borges N, 1997, J PHARMACOL EXP THER, V282, P812
[6]   Rat liver catechol-O-methyltransferase kinetics and assay methodology [J].
Borges, N ;
Vieira-Coelho, MA ;
Parada, A ;
Soares-da-Silva, P .
JOURNAL OF ENZYME INHIBITION, 1998, 13 (06) :473-483
[7]   TIGHT-BINDING INHIBITORS .1. KINETIC-BEHAVIOR [J].
CHA, S .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (23) :2177-2185
[8]   TIGHT-BINDING INHIBITORS .2. NON-STEADY STATE NATURE OF INHIBITION OF MILK XANTHINE-OXIDASE BY ALLOPURINOL AND ALLOXANTHINE AND OF HUMAN ERYTHROCYTIC ADENOSINE DEAMINASE BY COFORMYCIN [J].
CHA, S ;
AGARWAL, RP ;
PARKS, RE .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (23) :2187-2197
[9]  
COLIGAN JE, 1997, CURRENT PROTOCOLS PR
[10]  
GULDBERG HC, 1975, PHARMACOL REV, V27, P135